Licensing Molecular Beacons Technology

            Public Health Research Institute Properties, Inc. (PHRI) offers non-exclusive worldwide licenses for the molecular beacons technology in a variety of fields and for a variety of uses. A license under PHRI's patents includes rights to seven different patents and patent applications and further improvements to the technology. These patents can be viewed and printed. Issued claims describe molecular beacon probes, kits, and assays. Patents that cover additional aspects of molecular beacons technology are pending. Foreign counterparts are issued or pending in Canada, Europe, Japan, China and Australia. Licensing income received by PHRI is used to support further biomedical research. Also, a license creates a contractual collaborative relationship with the laboratory of Drs. Fred Russell Kramer, Sanjay Tyagi, and Salvatore Marras, the inventors of the technology.

            For further information on licenses, please contact Dr. Fred Russell Kramer at the Public Health Research Institute - University of Medicine and Dentistry of New Jersey, 1-973-854-3370 (fred.kramer@umdnj.edu).

---

Products and Assays that Utilize Molecular Beacons Technology

  1.   Custom molecular beacon probes
  2.   Assay kits
  3.   Performance of assays for a fee
  4.   Performance of assays for internal quality control
  5.   Assay instruments


Fields of Use for Molecular Beacons Technology

  1.   Human in vitro diagnostics
         a. Testing for infectious agents
         b. Genetic testing
         c. Oncology
  2.   Research
  3.   GMO testing
  4.   Food testing
  5.   Veterinary diagnostics
  6.   Hybrid seed production
  7.   Agricultural infectious agents
  8.   Forensics
  9.   Paternity testing
10.   High-density probe arrays
11.   Industrial microbiology
12.   Blood products quality control
13.   Environmental pathogens

The fields of use are not limited to this list. New applications and fields for molecular beacons arise frequently.